EyePoint Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
EyePoint Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 52.2M shares, a 52% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 52.2M +17.9M +52% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 49.9M +15.6M +45.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 49M +15M +43.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 35.3M +1.24M +3.63% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 34.3M +254K +0.74% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 34.3M +255K +0.75% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 34.1M +177K +0.52% Dec 31, 2022 10-K 2024-03-08
Q3 2022 34.1M +5.3M +18.4% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 34.1M +5.3M +18.4% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 34M +5.31M +18.5% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 33.9M +15.8M +86.9% Dec 31, 2021 10-K 2023-03-10
Q3 2021 28.8M -103M -78.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 28.8M -96.4M -77% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 28.7M -96M -77% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 18.1M +7.2M +65.8% Dec 31, 2020 10-K 2022-03-14
Q3 2020 131M +23.4M +21.7% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 125M +18.9M +17.8% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 125M +29.2M +30.5% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 10.9M -84.4M -88.5% Dec 31, 2019 10-K 2021-03-12
Q3 2019 108M +13.3M +14.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 106M +31.8M +42.7% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 95.6M +41.6M +77.2% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 95.4M +50.1M +111% Dec 31, 2018 10-K 2020-03-16
Q3 2018 94.7M +54.5M +136% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 74.5M +35.2M +89.3% Jun 30, 2018 10-KT 2019-03-18
Q1 2018 53.9M +18.2M +51.1% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 45.3M +11.1M +32.4% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 40.2M +6.02M +17.6% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 39.4M +5.18M +15.2% Jun 30, 2017 10-KT 2019-03-18
Q1 2017 35.7M +1.59M +4.65% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 34.2M +4.55M +15.4% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 34.2M +4.76M +16.2% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 34.2M +4.76M +16.2% Jun 30, 2016 10-K 2017-09-13
Q1 2016 34.1M +4.67M +15.9% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 29.6M +216K +0.73% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 29.4M +79.8K +0.27% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 29.4M +114K +0.39% Jun 30, 2015 10-K 2016-09-13
Q1 2015 29.4M +168K +0.57% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 29.4M +2.11M +7.74% Dec 31, 2014 10-Q 2015-02-06
Q3 2014 29.3M +2.55M +9.5% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 29.3M +6M +25.8% Jun 30, 2014 10-K 2015-09-10
Q1 2014 29.2M +5.95M +25.5% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 27.3M +4M +17.2% Dec 31, 2013 10-Q 2014-02-12
Q3 2013 26.8M +3.49M +15% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 23.3M +2.49M +12% Jun 30, 2013 10-K 2014-09-11
Q1 2013 23.3M +2.49M +12% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 23.3M +2.49M +12% Dec 31, 2012 10-Q 2013-02-08
Q3 2012 23.3M +2.49M +12% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 20.8M +54K +0.26% Jun 30, 2012 10-K 2013-09-27
Q1 2012 20.8M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 20.8M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 20.8M Sep 30, 2011 10-Q/A 2011-11-09
Q2 2011 20.7M Jun 30, 2011 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.